No edit summary |
|||
Line 27: | Line 27: | ||
* [[Brompheniramine]] |
* [[Brompheniramine]] |
||
* [[Chlorpheniramine]] |
* [[Chlorpheniramine]] |
||
* [[Dexchlorpheniramine]] |
|||
* [[Pheniramine]] |
* [[Pheniramine]] |
||
Revision as of 07:48, 11 January 2010
![]() | |
Clinical data | |
---|---|
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Elimination half-life | 25 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.595 ![]() |
Chemical and physical data | |
Formula | C16H19BrN2 |
Molar mass | 319.24 g/mol g·mol−1 |
(verify) |
Dexbrompheniramine (Drixoral) is an antihistamine with anticholinergic properties used to treat allergic conditions such as hay fever or urticaria. It is the pharmacologically active dextrorotatory isomer of brompheniramine. It is marketed under the name Drixoral in the US and Canada, which is a combination of dexbrompheniramine and pseudoephedrine.
See also
References
H1 |
| ||||
---|---|---|---|---|---|
H2 |
| ||||
H3 |
| ||||
H4 |
| ||||